News

AbstractBackground and aim of the studyWild-type transthyretin cardiac amyloidosis (ATTRwt-CA) is an increasingly recognized disease in elderly individuals. We…

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.If you or a loved one has been diagnosed with…

Data availabilityThe datasets generated and analysed during the current study are available from the corresponding author on reasonable request.FundingOpen access…

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.If you have been diagnosed with transthyretin amyloid…

The rare disease community needs More Access Than You Can Imagine! This Rare Disease Day, the NORD Rare Disease Centers of Excellence (RD CoE) Program will…

The Rare Disease Symposium 2026 is hosted by the UCSF Catalyst Program and Institute for Human Genetics, in partnership with Foundation Ipsen. Rare diseases affect…

A 48-year-old woman with conjunctival amyloidosis and a history of oral ulcers (Fig. 1), previously treated with amoxicillin for presumed acute pharyngitis,…

BackgroundCarpal tunnel syndrome (CTS) has been recognized as a potential early manifestation of systemic amyloidosis; however, its prognostic implications for…

AbstractIntroductionTransthyretin amyloidosis (ATTR) is a multisystemic disease impacting quality of life (QOL) through various symptoms. The Transthyretin…

AbstractBACKGROUND:Diagnosing cardiac amyloidosis (CA) on echocardiography can be challenging due to the imaging overlap between CA and more prevalent causes of a…